Inhibikase Therapeutics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-0
Book Value Per Share
$2
Free Cash Flow Per Share
$-0
Cash Per Share
$2
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-36.0%
Return on Assets
-34.5%
Return on Invested Capital
-30.7%
Debt to Equity
—
Current Ratio
21.70
Quick Ratio
21.70
Asset Turnover
0.03
R&D / Revenue
801.9%
SBC / Revenue
412.1%
Capex / Revenue
0.4%
Working Capital
$172M
Net Current Asset Value
$172M
Invested Capital
$173M
OCF / Net Income
0.58
FCF / Net Income
0.58
Accruals Ratio (Sloan)
-11.3%
Net Debt
$-218M
Net Debt / EBITDA
4.21
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-2073.77
Tangible Common Equity
$173M
TCE / Total Assets
95.4%
NOPAT
$-41M
Cash ROIC
-20.8%
WC / Revenue
4624.6%
Capex / D&A
0.22
Reinvestment Rate
0.1%
Asset Growth vs Revenue Growth
-163.7%
Revenue 5Y CAGR
39.7%
Book Value 5Y CAGR
77.6%
Stock Price (FY-end)
$2
Market Cap
$202M
P/S Ratio
54.25
P/B Ratio
1.17
P/TB Ratio
1.17
Enterprise Value
$-17M
EV / Sales
-4.52
FCF Yield
-13.8%
Shareholder Yield
-7.6%
R&D Yield
14.8%
Capex Yield
0.0%
Shares Variation (YoY)
314.6%
Beta (5Y)
0.95
Cost of Equity
9.3%
Cost of Debt (after tax)
—
52W High
$3
52W Low
$1
Trailing Return 1Y
-32.8%
Trailing Return 5Y
-96.5%
F-Score (Piotroski)
3.00
Z-Score (Altman)
13.68
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.